• Featured Product
  • KD/KO Validated

PARK2/Parkin Monoklonaler Antikörper

PARK2/Parkin Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

2H5A7

Kat-Nr. : 66674-1-PBS

Synonyme

Parkin, PARK2, Parkin RBR E3 ubiquitin-protein ligase, EC:2.3.2.31, E3 ubiquitin-protein ligase parkin



Geprüfte Anwendungen

Produktinformation

66674-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA PARK2/Parkin und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen PARK2/Parkin fusion protein Ag5179
Vollständiger Name Parkinson disease (autosomal recessive, juvenile) 2, parkin
Berechnetes Molekulargewicht 52 kDa
Beobachtetes Molekulargewicht 42-52 kDa
GenBank-ZugangsnummerBC022014
Gene symbol Parkin
Gene ID (NCBI) 5071
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Parkin, a RING-type E3 ubiquitin-protein ligase, is involved in the ubiquitination pathway and contributes to protection from neurotoxicity induced by unfolded protein stresses. Its ubiquitin-protein ligase activity promotes the degradation of a viariety of proteins including itself. Mutations in Parkin are implicated in the pathogenesis of autosomal recessive familial Parkinson's disease. It has 8 isoforms produced by alternative splicing.